Maximise QOF targets with minimal effort

Covid Expansion Fund

With QOF no longer protected from this financial year, GP practices, PCNs and other primary care groups can manage backlogs in chronic condition reviews by using the Medloop Patient Management Optimiser. 

An additional £120 million of funding is being released by the government to enable primary care to tackle the backlogs for appointments and other services which were not possible to complete during the pandemic. 

The PMO is an end to end software tool which enables primary care practitioners to treat and manage the health of their patient population.  

It is designed to deliver quality reviews for patients with long term conditions and comes with an additional booking tool which can be used for multiple services from cancer screening to vaccination clinics.

All this means that GPs can maximise the number of patients who have completed reviews for long term conditions and, using the Covid Capacity Expansion Fund, without incurring any additional costs. 

The CCEF has clearly defined priority goals outlined by NHS England and the PMO meets the requirement for an eligible funding opportunity. By using the CCEF for chronic conditions – which comes complete with a booking tool which can be used for services such as vaccination clinics or cancer screenings – practices can easily demonstrate how they have met the official criteria.

It’s a win – win for patients and healthcare providers – and the Medloop team is ready to help you take the next step in using the latest technology to streamline working practices.  


This money has to be used by the 30th September 2021 and is exclusively available to support the expansion of primary care capacity – so now is the time to get in touch and see how we can help your team deliver excellent care for your patients without the clerical burden of other providers and with our unique tools which code directly into the patient record. 

NHS England have confirmed that practices can access the money individually rather than solely via a PCN although the latter is the expected mode of delivery for the majority of the funding. The decision on where funding is allocated is via the CCG/ICS.

Additional Roles Reimbursement Scheme (ARRS)

Other centrally allocated funding is also available for practices who want to look at ways of improving their efficiency for chronic condition reviews.

One of these is the Additional Roles Reimbursement Scheme, allowing PCNs to share resources across multiple practices.

With one data sharing agreement and the ability to log into the PMO dashboard with one username yet access multiple surgery records, it is the perfect tool to complement the shared resources model. 

The drive towards primary care networks has resulted in an increase in funding to £746 million this financial year. 

New roles will also now be included as the expansion of PCNs continue and, significantly, the limit on the number of pharmacy technicians who can be employed using ARRS has been removed. 

In order to tackle the patient backlog, it has also been announced that PCNs will be able to transfer over more pharmacists from the ‘Clinical Pharmacist in General Practice’ scheme to their PCN between 1st April and 30th September 2021.

There are a number of key roles which can be funded by ARRS who could be at the centre of a streamlined review process using the patient management optimiser. 

Clinical pharmacists and pharmacy technicians working in a patient facing role are ideally placed to focus their time on reviewing urgent and more critical patients – highlighted in the PMO by our unique risk stratification tool. 

Contact us to arrange a demonstration and find out how we can work to deliver the maximum benefits for your practice.


Other articles you might find interesting